Jan 12, 2026
How does remission achieved with GLP‑1/GIP drugs compare to remission after stopping the drugs in randomized trials?
Randomized trials show GLP‑1 and GLP‑1/GIP drugs (like semaglutide and tirzepatide) produce substantial weight loss and short‑term improvements in cardiometabolic markers while on treatment, but those...